Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06710847
Title A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors (SYLVER)
Acronym SYLVER
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | AUS

Facility Status City State Zip Country Details
GSK Investigational Site Denver Colorado 80218 United States Details
GSK Investigational Site Augusta Georgia 30912 United States Details
GSK Investigational Site Detroit Michigan 48201 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19104 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19107 United States Details
GSK Investigational Site Melbourne Victoria 3000 Australia Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Shizuoka 411-8777 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Tokyo 135-8550 Japan Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Nijmegen 6525 GA Netherlands Details
GSK Investigational Site Rotterdam 3015 GD Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field